ResearcherJohns Hopkins UniversityNo recent work listed

Nina J. Chu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5005604307. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 1 paper

Papers 1

Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development. Co-author DOI 10.1158/1940-6207.capr-20-0053 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert A. Anders · 1 shared paper, 2020 · strength 0.11
- Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053 ↗
Elana Judith Fertig · 1 shared paper, 2020 · strength 0.11
- Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053 ↗
Alexander C. Hopkins · 1 shared paper, 2020 · strength 0.11
- Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053 ↗
Elizabeth M. Jaffee · 1 shared paper, 2020 · strength 0.11
- Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053 ↗
Jacquelyn W. Zimmerman · 1 shared paper, 2020 · strength 0.11
- Paper Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Developmen… DOI 10.1158/1940-6207.capr-20-0053 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.